Showing results (151-160 of 173) with videos related to

Sort By:
Pageof 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2021
Clinical Implications of Minimal Residual Disease Detection in Infants With KMT2A-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 ProtocolJanine Stutterheim, Inge M van der Sluis, Paola de Lorenzo, et al.
Molecular Metabolism|October 21, 2025
Canagliflozin synergises with serine restriction mediating anti-leukaemic effects in T-cell acute lymphoblastic leukaemiaFernando M Ponce-Garcia, Yasmin R Jenkins, Victoria D Assmann, et al.
Frontiers in Immunology|October 10, 2017
Corrigendum: Clinical and Molecular Heterogeneity of RTEL1 DeficiencyCarsten Speckmann, Sushree Sangita Sahoo, Marta Rizzi, et al.
Frontiers in Immunology|May 17, 2017
Clinical and Molecular Heterogeneity of RTEL1 DeficiencyCarsten Speckmann, Sushree Sangita Sahoo, Marta Rizzi, et al.
The Lancet. Haematology|June 25, 2021
Severe toxicity free survival: physician-derived definitions of unacceptable long-term toxicities following acute lymphocytic leukaemiaLiv Andrés-Jensen, Andishe Attarbaschi, Edit Bardi, et al.
Nature Cancer|January 22, 2021
Metabolic adaptation of acute lymphoblastic leukemia to the central nervous system microenvironment is dependent on Stearoyl CoA desaturaseAngela Maria Savino, Sara Isabel Fernandes, Orianne Olivares, et al.
Pageof 18